Anne Andert1, Tom Florian Ulmer2, Wenzel Schöning2, Daniela Kroy3, Marc Hein4, Patrick Hamid Alizai2, Christoph Heidenhain5, Ulf Neumann2, Maximilian Schmeding2. 1. Department of General, Visceral and Transplant Surgery, Uniklinik RWTH Aachen, Aachen, Germany. Electronic address: aandert@ukaachen.de. 2. Department of General, Visceral and Transplant Surgery, Uniklinik RWTH Aachen, Aachen, Germany. 3. Department of Internal Medicine, Uniklinik RWTH Aachen, Aachen, Germany. 4. Department of Anaesthesiology, Uniklinik RWTH Aachen, Aachen, Germany. 5. Department of General and Visceral Surgery, Sana Hospital Düsseldorf-Gerresheim, Germany.
Abstract
BACKGROUND: The potential effect of graft steatosis on the postoperative liver function is discussed controversially. The present study aimed to evaluate the effect of the donor liver microvesicular steatosis on the postoperative outcome after liver transplantation. METHODS: Ninety-four patients undergoing liver transplantation at the University Hospital Aachen were included in this study. The patient cohort was divided into three groups according to the grade of microvesicular steatosis (MiS): MiS <30% (n=27), MiS 30%-60% (n=41) and MiS >60% (n=26). The outcomes after liver transplantation were evaluated, including the 30-day and 1-year patient and graft survival rates and the incidences of early allograft dysfunction (EAD) and primary nonfunction (PNF). RESULTS: The incidences of EAD and PNF did not differ significantly between the groups. We observed 5 cases of PNF, one occurred in the MiS <30% group and 4 in the MiS 30%-60% group. The 30-day and 1-year graft survivals did not differ significantly between groups. The 30-day patient survival rates were 100% in all groups. The 1-year patient survival rates were 94.4% in the MiS <30% group, 87.9% in the MiS 30%-60% group and 90.9% in the MiS >60% group. CONCLUSION: Microvesicular steatosis of donor livers has no negative effect on the postoperative outcome after liver transplantation.
BACKGROUND: The potential effect of graft steatosis on the postoperative liver function is discussed controversially. The present study aimed to evaluate the effect of the donorliver microvesicular steatosis on the postoperative outcome after liver transplantation. METHODS: Ninety-four patients undergoing liver transplantation at the University Hospital Aachen were included in this study. The patient cohort was divided into three groups according to the grade of microvesicular steatosis (MiS): MiS <30% (n=27), MiS 30%-60% (n=41) and MiS >60% (n=26). The outcomes after liver transplantation were evaluated, including the 30-day and 1-year patient and graft survival rates and the incidences of early allograft dysfunction (EAD) and primary nonfunction (PNF). RESULTS: The incidences of EAD and PNF did not differ significantly between the groups. We observed 5 cases of PNF, one occurred in the MiS <30% group and 4 in the MiS 30%-60% group. The 30-day and 1-year graft survivals did not differ significantly between groups. The 30-day patient survival rates were 100% in all groups. The 1-year patient survival rates were 94.4% in the MiS <30% group, 87.9% in the MiS 30%-60% group and 90.9% in the MiS >60% group. CONCLUSION:Microvesicular steatosis of donor livers has no negative effect on the postoperative outcome after liver transplantation.
Authors: Faisal A Abaalkhail; Mohammed I Al Sebayel; Mohammed A Shagrani; Wael A O'Hali; Nasser M Almasri; Abduljaleel A Alalwan; Mohammed Y Alghamdi; Hamad Al-Bahili; Mohammed S AlQahtani; Saleh I Alabbad; Waleed K Al-Hamoudi; Saleh A Alqahtani Journal: Saudi Med J Date: 2021-09 Impact factor: 1.422
Authors: Sanjaya K Satapathy; Humberto C Gonzalez; Jason Vanatta; Andrew Dyer; Wesley Angel; Simonne S Nouer; Mehmet Kocak; Satish K Kedia; Yu Jiang; Ian Clark; Nour Yadak; Nosratollah Nezakagtoo; Ryan Helmick; Peter Horton; Luis Campos; Uchenna Agbim; Benedict Maliakkal; Daniel Maluf; Satheesh Nair; Hollis H Halford; James D Eason Journal: PLoS One Date: 2020-05-14 Impact factor: 3.240
Authors: Justin A Steggerda; Matthew B Bloom; Mazen Noureddin; Todd V Brennan; Tsuyoshi Todo; Nicholas N Nissen; Andrew S Klein; Irene K Kim Journal: PLoS One Date: 2020-04-02 Impact factor: 3.240
Authors: Justin A Steggerda; Daniel Borja-Cacho; Todd V Brennan; Tsuyoshi Todo; Nicholas N Nissen; Matthew B Bloom; Andrew S Klein; Irene K Kim Journal: Transplant Direct Date: 2022-01-13